Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
BiondVax Pharmaceuticals Ltd.
Nov 18, 2019
Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial
Oct 07, 2019
BiondVax Receives EUR4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial
Aug 28, 2019
BiondVax Welcomes New Chairman of the Board and Announces Second Quarter 2019 Financial Results
Jul 16, 2019
BiondVax Announces Rights Offering Fully Subscribed at US$20 Million
Jul 08, 2019
First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial
Jun 26, 2019
European Investment Bank VP Attends Signature Event at BiondVax Extending Financing Agreement With BiondVax to EUR24million
Jun 18, 2019
Patent Covering Manufacturing Process of BiondVax's M-001 Universal Flu Vaccine Allowed in USA and Japan
Jun 10, 2019
BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process
May 30, 2019
BiondVax Announces First Quarter 2019 Financial Results
May 13, 2019
BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at 18th MIXiii-BIOMED Conference
Apr 30, 2019
BiondVax Announces Fourth Quarter and Full Year 2018 Financial Results and Update
Apr 22, 2019
European Investment Bank (EIB) Extends Financing Agreement to EUR24 Million Total in Support of BiondVax's Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial
Apr 15, 2019
BiondVax Universal Flu Vaccine Patent Application Accepted in Australia
Mar 28, 2019
BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 Conference
Mar 21, 2019
Last Participant out in USA Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate
Nov 26, 2018
BiondVax CEO to Present at 'World Vaccine Congress 2018 San Diego' About BiondVax's Phase 3 Universal Flu Vaccine Candidate
Nov 19, 2018
BiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results
Nov 13, 2018
BiondVax Announces Third Quarter 2018 Financial Results
Oct 24, 2018
BiondVax's Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season's Enrollment of 4,098 Participants
Oct 22, 2018
BiondVax Receives EUR8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial
‹‹
Page 2
››
Latest News
Apr 19, 2024
New Jersey Resources Board of Directors Declares Quarterly Dividend
Apr 19, 2024
Greasecycle Founder and President Selected as North Carolina's Small Business Person of the Year
Apr 19, 2024
OKI Group Revises OKI Group Environmental Vision 2030/2050
Apr 19, 2024
Media Alert: BrainChip Highlights the 2nd Generation Akida at tinyML Summit 2024
Apr 19, 2024
Avangrid Launches Lineworker Recruitment Efforts to Mark Lineworker Appreciation Day
Apr 19, 2024
Williams to Volunteer at nearly 100 Community Projects Across 17 States
Apr 19, 2024
Global Oil and Gas Pipes Strategic Research Report 2024: Market to Surpass $110 Billion by 2030 - Demand...
Apr 19, 2024
Proemion Holding GmbH Agrees to Acquire TrendMiner NV to Expand Industrial Asset-Monitoring and Analytics...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events